HLA-A Antikörper (AA 24-365)
HLA-A
Reaktivität: Human
WB, ELISA
Wirt: Maus
Monoclonal
2D6
unconjugated
Produktnummer ABIN1326934
-
-
Target
Alle HLA-A Antikörper anzeigen
-
HLA-A
(Major Histocompatibility Complex, Class I, A (HLA-A))
-
Bindungsspezifität
-
AA 24-365
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Monoklonal
-
Konjugat
-
Dieser HLA-A Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA
-
Verwendungszweck
-
Mouse monoclonal antibody raised against a full-length recombinant HLA-A.
-
Sequenz
-
AGSHSMRYFF TSVSRPGRGE PRFIAVGYVD DTQFVRFDSD AASQKMEPRA PWIEQEGPEY WDQETRNMKA HSQTDRANLG TLRGYYNQSE DGSHTIQIMY GCDVGPDGRF LRGYRQDAYD GKDYIALNED LRSWTAADMA AQITKRKWEA VHAAEQRRVY LEGRCVDGLR RYLENGKETL QRTDPPKTHM THHPISDHEA TLRCWALGFY PAEITLTWQR DGEDQTQDTE LVETRPAGDG TFQKWAAVVV PSGEEQRYTC HVQHEGLPKP LTLRWELSSQ PTIPIVGIIA GLVLLGAVIT GAVVAAVMWR RKSSDRKGGS YTQAASSDSA QGSDVSLTAC KV
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody Reactive Against Recombinant Protein.
-
Immunogen
-
HLA-A (AAH03069, 24 a.a. ~ 365 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Klon
-
2D6
-
Isotyp
-
IgG2a
-
Top Product
-
Discover our top product HLA-A Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Buffer
-
In 1x PBS, pH 7.4
-
Handhabung
-
Aliquot to avoid repeated freezing and thawing.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Target
-
HLA-A
(Major Histocompatibility Complex, Class I, A (HLA-A))
-
Andere Bezeichnung
-
HLA-A (HLA-A Produkte)
-
Synonyme
-
HLAA antikoerper, major histocompatibility complex, class I, A antikoerper, HLA-A antikoerper
-
Hintergrund
-
Full Gene Name: major histocompatibility complex, class I, A
Synonyms: HLAA
-
Gen-ID
-
3105
-
Pathways
-
T-Zell Rezeptor Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-